Blog
Careers, Industries & Professions
Derivatives
Economics
Equities & Stocks
Foreign Exchange
International Business
Management & Leadership
Marketing & Sales
Personal Finance
Real Estate
AstraZeneca suffers investor rebellion over pay
AstraZeneca chief executive Pascal Soriot has suffered a shareholder rebellion on pay after the drugmaker significantly increased his potential bonus for the second year in a row. About 40 per…